Down-Regulation of ICOS Ligand by Interaction With ICOS Functions as a Regulatory Mechanism for Immune Responses

Journal of Immunology - United States
doi 10.4049/jimmunol.180.8.5222
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy

Current Protein and Peptide Science
MedicineBiochemistryCell BiologyMolecular Biology
2018English

Roquin Paralogs Add a New Dimension to ICOS Regulation

Immunity
Infectious DiseasesAllergyImmunology
2013English

Th1 Cytokine Responses Fail to Effectively Control Chlamydia Lung Infection in ICOS Ligand Knockout Mice

Journal of Immunology
AllergyImmunology
2010English

ICOS Controls the Pool Size of Effector-Memory and Regulatory T Cells

Journal of Immunology
AllergyImmunology
2008English

ICOS Regulates ILC2s in Asthma

Oncotarget
Oncology
2015English

Down-Regulation of Macrophage Immune Activity by Natural CD8+ Regulatory T Cells*

Folia Biologica
BiochemistryMedicineGeneticsMolecular Biology
2013English

ICOS Co-Stimulation: Friend or Foe?

Frontiers in Immunology
AllergyImmunology
2016English

Mechanism for Down-Regulation of CD28 by Nef

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2001English

Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of Il10 but Readily Downregulate Expression of Foxp3

Journal of Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy